Update shared on 26 Nov 2025
Fair value Increased 3.55%Elopak's analyst price target has been raised from NOK 52.82 to NOK 54.69, as analysts cite improved revenue growth expectations, even though there is a slight decline in profit margin forecasts.
What's in the News
- Elopak ASA (OB:ELO) has been added to the S&P Global BMI Index (Key Developments).
- The company commenced a share repurchase program on September 15, 2025. The program allows buybacks of up to 10% of the current share capital, with purchases authorized until no later than June 30, 2026 (Key Developments).
- Elopak completed the repurchase of 600,000 shares for NOK 23.57 million as part of the ongoing buyback program announced in August 2024 (Key Developments).
Valuation Changes
- Consensus Analyst Price Target: Increased from NOK 52.82 to NOK 54.69, reflecting an improved outlook.
- Discount Rate: Decreased marginally from 6.63% to 6.61%.
- Revenue Growth: Revised upward from 6.92% to 7.82%.
- Net Profit Margin: Slightly reduced from 7.07% to 6.94%.
- Future P/E Ratio: Increased from 14.51x to 14.73x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.